201 related articles for article (PubMed ID: 34465474)
1. Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
Batool R; Tahir Yousafzai M; Qureshi S; Ali M; Sadaf T; Mehmood J; Ashorn P; Naz Qamar F
Vaccine; 2021 Sep; 39(40):5858-5865. PubMed ID: 34465474
[TBL] [Abstract][Full Text] [Related]
2. Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.
Thobani RS; Yousafzai MT; Sultana S; Kazi AM; Jan M; Rafey A; Khan A; Irfan S; Ujjan IU; Brown N; Mårtensson A; Qamar FN
Vaccine; 2022 Aug; 40(36):5391-5398. PubMed ID: 35945044
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study.
Yousafzai MT; Karim S; Qureshi S; Kazi M; Memon H; Junejo A; Khawaja Z; Ur Rehman N; Ansari MS; Ali R; Ujjan IU; Lohana HM; Memon NM; Hussain M; Nigar R; Bar-Zeev N; Qamar FN
Lancet Glob Health; 2021 Aug; 9(8):e1154-e1162. PubMed ID: 34297962
[TBL] [Abstract][Full Text] [Related]
4. Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
Batool R; Yousafzai MT; Qureshi S; Muhammad S; Qazi I; Sadaf T; Ashorn P; Qamar FN
Vaccine; 2023 Aug; 41(37):5376-5382. PubMed ID: 37463829
[TBL] [Abstract][Full Text] [Related]
5. Coverage survey of typhoid conjugate vaccine among children aged 6 months to 15 years in an urban slum settlement of Lyari Town Karachi, Pakistan.
Batool R; Qureshi S; Haq Z; Yousafzai MT; Salam RA; Ali R; Sadaf T; Ali M; Qamar FN
PLoS One; 2023; 18(8):e0289582. PubMed ID: 37549155
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ
Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501
[TBL] [Abstract][Full Text] [Related]
7. Strategies to Improve Coverage of Typhoid Conjugate Vaccine (TCV) Immunization Campaign in Karachi, Pakistan.
Qamar FN; Batool R; Qureshi S; Ali M; Sadaf T; Mehmood J; Iqbal K; Sultan A; Duff N; Yousafzai MT
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33228111
[TBL] [Abstract][Full Text] [Related]
8. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.
Garrett DO; Longley AT; Aiemjoy K; Yousafzai MT; Hemlock C; Yu AT; Vaidya K; Tamrakar D; Saha S; Bogoch II; Date K; Saha S; Islam MS; Sayeed KMI; Bern C; Shakoor S; Dehraj IF; Mehmood J; Sajib MSI; Islam M; Thobani RS; Hotwani A; Rahman N; Irfan S; Naga SR; Memon AM; Pradhan S; Iqbal K; Shrestha R; Rahman H; Hasan MM; Qazi SH; Kazi AM; Saddal NS; Jamal R; Hunzai MJ; Hossain T; Marks F; Carter AS; Seidman JC; Qamar FN; Saha SK; Andrews JR; Luby SP
Lancet Glob Health; 2022 Jul; 10(7):e978-e988. PubMed ID: 35714648
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors Associated with Extensively Drug-Resistant Typhoid in an Outbreak Setting of Lyari Town Karachi, Pakistan.
Batool R; Qureshi S; Yousafzai MT; Kazi M; Ali M; Qamar FN
Am J Trop Med Hyg; 2022 Mar; 106(5):1379-83. PubMed ID: 35344928
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
Yousafzai MT; Qamar FN; Shakoor S; Saleem K; Lohana H; Karim S; Hotwani A; Qureshi S; Masood N; Rauf M; Khanzada JA; Kazi M; Hasan R
Clin Infect Dis; 2019 Feb; 68(Suppl 1):S16-S21. PubMed ID: 30767003
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitudes, and practices of the general population of Pakistan regarding typhoid conjugate vaccine: findings of a cross-sectional study.
Tahir MJ; Zaman M; Saffi J; Asghar MS; Tariq W; Ahmed F; Islam R; Farooqui US; Ullah I; Saqlain M; Ullah K; Ahmed A
Front Public Health; 2023; 11():1151936. PubMed ID: 37333546
[TBL] [Abstract][Full Text] [Related]
12. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
Hoffman SA; LeBoa C; Date K; Haldar P; Harvey P; Shimpi R; An Q; Zhang C; Jayaprasad N; Horng L; Fagerli K; Borhade P; Daruwalla S; Dharmapalan D; Gavhane J; Joshi S; Rai R; Rathod V; Shetty K; Warrier DS; Yadav S; Chakraborty D; Bahl S; Katkar A; Kunwar A; Yewale V; Andrews JR; Bhatnagar P; Dutta S; Luby SP
Clin Infect Dis; 2023 Jul; 77(1):138-144. PubMed ID: 36947143
[TBL] [Abstract][Full Text] [Related]
13. Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
Shakya M; Colin-Jones R; Theiss-Nyland K; Voysey M; Pant D; Smith N; Liu X; Tonks S; Mazur O; Farooq YG; Clarke J; Hill J; Adhikari A; Dongol S; Karkey A; Bajracharya B; Kelly S; Gurung M; Baker S; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ;
N Engl J Med; 2019 Dec; 381(23):2209-2218. PubMed ID: 31800986
[TBL] [Abstract][Full Text] [Related]
14. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
[TBL] [Abstract][Full Text] [Related]
15. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
[TBL] [Abstract][Full Text] [Related]
16. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
Qamar FN; Yousafzai MT; Khaliq A; Karim S; Memon H; Junejo A; Baig I; Rahman N; Bhurgry S; Afroz H; Sami U
Vaccine; 2020 Apr; 38(19):3518-3523. PubMed ID: 32201138
[TBL] [Abstract][Full Text] [Related]
17. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries.
Shakya M; Neuzil KM; Pollard AJ
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S770-S774. PubMed ID: 34374785
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
Patel PD; Patel P; Liang Y; Meiring JE; Misiri T; Mwakiseghile F; Tracy JK; Masesa C; Msuku H; Banda D; Mbewe M; Henrion M; Adetunji F; Simiyu K; Rotrosen E; Birkhold M; Nampota N; Nyirenda OM; Kotloff K; Gmeiner M; Dube Q; Kawalazira G; Laurens MB; Heyderman RS; Gordon MA; Neuzil KM;
N Engl J Med; 2021 Sep; 385(12):1104-1115. PubMed ID: 34525285
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis.
Batool R; Qamar ZH; Salam RA; Yousafzai MT; Ashorn P; Qamar FN
Lancet Glob Health; 2024 Apr; 12(4):e589-e598. PubMed ID: 38485426
[TBL] [Abstract][Full Text] [Related]
20. The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
Kulkarni PS; Potey AV; Bharati S; Kunhihitlu A; Narasimha B; Yallapa S; Dharmadhikari A; Gavade V; Kamat CD; Mallya A; Sarma AD; Goel S; Pisal SS; Poonawalla CS; Venkatesan R; Jones E; Flaxman A; Kim YC; Pollard AJ;
Lancet; 2024 Apr; 403(10436):1554-1562. PubMed ID: 38555928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
